Citation Impact
Citing Papers
The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity
2016
Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?
2016
New insights into the pathophysiology of dyslipidemia in type 2 diabetes
2015
Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease
2021
Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD
2015
Glutathione peroxidases
2012 Standout
HDL particle size and the risk of coronary heart disease in apparently healthy men and women: The EPIC-Norfolk prospective population study
2009
Angiographically-assessed coronary artery disease associates with HDL particle size in women
2012
Lipid Simulations: A Perspective on Lipids in Action
2011
Chronic inflammation in the etiology of disease across the life span
2019 Standout
The Evolving Understanding and Approach to Residual Cardiovascular Risk Management
2020
The role of pathway-selective insulin resistance and responsiveness in diabetic dyslipoproteinemia
2012
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
2019 Standout
Macrophages in the Pathogenesis of Atherosclerosis
2011 Standout
The changing landscape of atherosclerosis
2021 StandoutNature
Atherosclerosis: current pathogenesis and therapeutic options
2011 Standout
Mechanisms and disease consequences of nonalcoholic fatty liver disease
2021
Macrophages in atherosclerosis: a dynamic balance
2013 Standout
Statin use and non-alcoholic steatohepatitis in at risk individuals
2015
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
Non-alcoholic fatty liver disease
2021 Standout
Plasma pre β-HDL formation is decreased by atorvastatin treatment in type 2 diabetes mellitus: Role of phospholipid transfer protein
2009
Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: Roles of pre β-HDL, phospholipid transfer protein and cholesterol esterification
2007
The immune system in atherosclerosis
2011 Standout
Dynamics and functions of lipid droplets
2018 Standout
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
2017 Standout
Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not defective despite low high-density lipoprotein cholesterol
2008
Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease
2020
Postprandial hypertriglyceridemia as a coronary risk factor
2014
Triglyceride Blisters in Lipid Bilayers: Implications for Lipid Droplet Biogenesis and the Mobile Lipid Signal in Cancer Cell Membranes
2010
Hypertriglyceridemia
2007
The mystery of membrane organization: composition, regulation and roles of lipid rafts
2017 Standout
Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation
2010
Causes and Consequences of Hypertriglyceridemia
2020
Atherosclerosis
2019 Standout
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
High-density lipoproteins: A consensus statement from the National Lipid Association
2013
Type 2 diabetes mellitus
2015 Standout
Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia Study
2011
The impact of plasma triglyceride and apolipoproteins concentrations on high-density lipoprotein subclasses distribution
2011
Molecular aspects of fructose metabolism and metabolic disease
2021
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
2011 Standout
Reduced high-density lipoprotein 2b in non-obese type 2 diabetic patients analysed by a microfluidic chip method in a case–control study
2009
NAFLD: A multisystem disease
2015 Standout
High-Density Lipoprotein Subfractions - What the Clinicians Need to Know
2013 Standout
Dietary carbohydrates and fats in nonalcoholic fatty liver disease
2021
Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro
2012
Biological activities of HDL subpopulations and their relevance to cardiovascular disease
2011
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Pathophysiology of diabetic dyslipidaemia: where are we?
2015
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
High Pre-β1 HDL Concentrations and Low Lecithin: Cholesterol Acyltransferase Activities Are Strong Positive Risk Markers for Ischemic Heart Disease and Independent of HDL-Cholesterol
2010
Adiposity and Insulin Resistance in Humans: The Role of the Different Tissue and Cellular Lipid Depots
2013
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors
2021
Sex differences in non-alcoholic fatty liver disease: hints for future management of the disease
2020
The Ability to Promote Efflux Via ABCA1 Determines the Capacity of Serum Specimens With Similar High-Density Lipoprotein Cholesterol to Remove Cholesterol From Macrophages
2010
Hypertriglyceridemia in the Genomic Era: A New Paradigm
2015
Circulating Triacylglycerol Signatures in Nonalcoholic Fatty Liver Disease Associated With the I148M Variant in PNPLA3 and With Obesity
2013
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Impact of the Association Between PNPLA3 Genetic Variation and Dietary Intake on the Risk of Significant Fibrosis in Patients With NAFLD
2020
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
2018 Standout
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
Selective Hepatic Insulin Resistance, VLDL Overproduction, and Hypertriglyceridemia
2012
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
The rs2294918 E434K variant modulates patatin‐like phospholipase domain‐containing 3 expression and liver damage
2015
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
2020 Standout
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
2023 Standout
Receptors for Purines and Pyrimidines
2012 Standout
Review article: the emerging role of genetics in precision medicine for patients with non‐alcoholic steatohepatitis
2020
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
NOX4 Pathway as a Source of Selective Insulin Resistance and Responsiveness
2012
Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
2017 Standout
Serum Amyloid A Activates the NLRP3 Inflammasome via P2X7 Receptor and a Cathepsin B-Sensitive Pathway
2011
Works of Sanni Söderlund being referenced
Serum, but not monocyte macrophage foam cells derived from low HDL-C subjects, displays reduced cholesterol efflux capacity
2008
Increased apolipoprotein E level and reduced high-density lipoprotein mean particle size associate with low high-density lipoprotein cholesterol and features of metabolic syndrome
2010
Family-specific aggregation of lipid GWAS variants confers the susceptibility to familial hypercholesterolemia in a large Austrian family
2017
Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity
2012
Impact of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab on the postprandial responses of triglyceride-rich lipoproteins in type II diabetic subjects
2019
Composition and lipid spatial distribution of HDL particles in subjects with low and high HDL-cholesterol
2010
Hypertriglyceridemia is associated with preβ-HDL concentrations in subjects with familial low HDL
2005
Interrelationships Between the Kinetics of VLDL Subspecies and HDL Catabolism in Abdominal Obesity: A Multicenter Tracer Kinetic Study
2014
Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans
2020
HDL Subspecies in Young Adult Twins: Heritability and Impact of Overweight
2009
Effect of HDL composition and particle size on the resistance of HDL to the oxidation
2010
Dual Metabolic Defects Are Required to Produce Hypertriglyceridemia in Obese Subjects
2011
Investigation of human apoB48 metabolism using a new, integrated non‐steady‐state model of apoB48 and apoB100 kinetics
2019
Kinetic and Related Determinants of Plasma Triglyceride Concentration in Abdominal Obesity
2015
Apolipoprotein B48 metabolism in chylomicrons and very low‐density lipoproteins and its role in triglyceride transport in normo‐ and hypertriglyceridemic human subjects
2019
Hepatic lipogenesis and a marker of hepatic lipid oxidation, predict postprandial responses of triglyceride‐rich lipoproteins
2014
Role of apolipoprotein C‐III overproduction in diabetic dyslipidaemia
2019
Paradoxical Dissociation Between Hepatic Fat Content and De Novo Lipogenesis Due to PNPLA3 Sequence Variant
2015
Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity
2017
Decreased High-Density Lipoprotein (HDL) Particle Size, Preβ-, and Large HDL Subspecies Concentration in Finnish Low-HDL Families
2006